CN117120433A - 化合物、化合物的制造方法及保管方法、靶向剂的制造方法、以及组合物 - Google Patents

化合物、化合物的制造方法及保管方法、靶向剂的制造方法、以及组合物 Download PDF

Info

Publication number
CN117120433A
CN117120433A CN202280024610.8A CN202280024610A CN117120433A CN 117120433 A CN117120433 A CN 117120433A CN 202280024610 A CN202280024610 A CN 202280024610A CN 117120433 A CN117120433 A CN 117120433A
Authority
CN
China
Prior art keywords
compound
reaction
ligand
acid
eluent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280024610.8A
Other languages
English (en)
Chinese (zh)
Inventor
渡边友理惠
大泽沙优里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Publication of CN117120433A publication Critical patent/CN117120433A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202280024610.8A 2021-03-26 2022-03-25 化合物、化合物的制造方法及保管方法、靶向剂的制造方法、以及组合物 Pending CN117120433A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-053783 2021-03-26
JP2021053783 2021-03-26
PCT/JP2022/014681 WO2022203082A1 (ja) 2021-03-26 2022-03-25 化合物、化合物の製造方法及び保管方法、ターゲッティング剤の製造方法、並びに組成物

Publications (1)

Publication Number Publication Date
CN117120433A true CN117120433A (zh) 2023-11-24

Family

ID=83397494

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280024610.8A Pending CN117120433A (zh) 2021-03-26 2022-03-25 化合物、化合物的制造方法及保管方法、靶向剂的制造方法、以及组合物

Country Status (5)

Country Link
US (1) US20240166631A1 (cg-RX-API-DMAC7.html)
EP (1) EP4317152A4 (cg-RX-API-DMAC7.html)
JP (2) JPWO2022203082A1 (cg-RX-API-DMAC7.html)
CN (1) CN117120433A (cg-RX-API-DMAC7.html)
WO (1) WO2022203082A1 (cg-RX-API-DMAC7.html)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111491670A (zh) * 2017-12-18 2020-08-04 詹森生物科技公司 多肽的放射性标记
US20200353105A1 (en) * 2019-05-10 2020-11-12 Janssen Biotech, Inc. Macrocyclic Chelators and Methods of Use Thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111491670A (zh) * 2017-12-18 2020-08-04 詹森生物科技公司 多肽的放射性标记
US20200353105A1 (en) * 2019-05-10 2020-11-12 Janssen Biotech, Inc. Macrocyclic Chelators and Methods of Use Thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WILSON Z. SHOU等: "Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI/MS/MS) bioanalysis of basic compounds", JOURNAL OF CHROMATOGRAPHY B, vol. 825, 5 February 2005 (2005-02-05), pages 186 - 192 *

Also Published As

Publication number Publication date
EP4317152A1 (en) 2024-02-07
JPWO2022203082A1 (cg-RX-API-DMAC7.html) 2022-09-29
EP4317152A4 (en) 2025-03-26
US20240166631A1 (en) 2024-05-23
JP2026012349A (ja) 2026-01-23
WO2022203082A1 (ja) 2022-09-29

Similar Documents

Publication Publication Date Title
US5573752A (en) Aromatic amide compounds and metal chelates thereof
CN101506179B (zh) 动态核极化(dnp)的方法及用于所述方法的化合物和组合物
KR102703312B1 (ko) 조영제
JP5271912B2 (ja) 標的化リガンドを固定化するための改良型リンカー
JP2014506869A (ja) プレターゲットキット、プレターゲット方法及びその使用試薬
JP2008515876A (ja) イメージング及び治療用のイメージング及び治療のエンドキットにおけるシュタウディンガーライゲーションの使用
JP2005504745A (ja) 大環状金属錯体及び生体分子との結合体の製造のためのその使用
US20060155120A1 (en) Optically pure and enriched isomers of chelating ligands and contrast agents
KR101413934B1 (ko) 라디칼 및 동적 핵 편극화 공정에서 상자성 물질로서의 그의 용도
Vitha et al. Gd (III) complex of a monophosphinate-bis (phosphonate) DOTA analogue with a high relaxivity; Lanthanide (III) complexes for imaging and radiotherapy of calcified tissues
ITMI992656A1 (it) Composti chelanti loro chelati con ioni metallici paramagnetici loro preparazione ed uso
Korn et al. Azide-and diazirine-modified membrane lipids: Physicochemistry and applicability to study peptide/lipid interactions via cross-linking/mass spectrometry
UA82642C2 (uk) Застосування перфторалкілвмісних комплексів металів як контрастних речовин в магнітно-резонансній томографії для візуалізації бляшок, пухлин і некрозів
Malikidogo et al. A phosphorylated zinc finger peptide bearing a gadolinium complex for zinc detection by MRI
EP4317152A1 (en) Compound, method for producing and method for storing compound, method for producing targeting agent, and composition
EP1302465A1 (en) Enhanced substrate imaging by reversible binding to a paramagnetic complex
Aime et al. para-Hydrogenation of unsaturated moieties on poly (lysine) derived substrates for the development of novel hyperpolarized MRI contrast agents
JP2024519031A (ja) コンジュゲート療法エンハンサーを含む組成物
Scheidt et al. The interaction of lipid modified pseudopeptides with lipid membranes
JP4903565B2 (ja) ランタニド錯体、調製及びその使用方法
EP0822180B1 (en) Chelating compounds, their chelates with paramagnetic metal ions, their preparation and use
CN119095830A (zh) 放射性金属络合物的制造方法
EP4741400A1 (en) Multimeric manganese contrast agents
JP7773989B2 (ja) 放射性ジルコニウム錯体の製造方法
KR20110099984A (ko) 분자영상 프로브 제조용 신규 리간드, 그 리간드를 포함하는 분자영상 프로브, 그 분자영상 프로브를 포함하는 분자영상 입자, 그 제조방법 및 그것을 포함하는 약학 조성물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination